Incyte Corporation (Nasdaq: INCY) announced today it will present at the
Leerink Partners Inaugural Immuno-Oncology Roundtable Conference on
Thursday, October 1, 2015 at 3:15 p.m. (EDT) in New York.
The presentation will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts. Investors interested in
listening to the live webcast should log on before the start time in
order to download any software required. A replay of the presentation
will be available.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics, primarily for oncology. For additional
information on Incyte, please visit the Company's web site at www.incyte.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005016/en/
Copyright Business Wire 2015